There is currently an open clinical trial of Ampligen on CFS, but it is open label and the patients need to pay for all costs related to the therapy.
“An Open-Label Study of Poly I: Poly C12U (Ampligen®) in Patients with Severely Debilitating Chronic Fatigue Syndrome (CFS)/Myalgic Encephalomyelitis (ME). The FDA approved the study for cost recovery. Patients enrolled in the study are responsible for costs related to the therapy, e.g., drug cost, infusion cost, cost of supplies, diagnostic and other laboratory testing.”
Ampligen doesn't have quite the side effect profile of an antiretroviral. It might even work better if it is open label and the patients have to pay full cost. The more expensive a placebo is, the better it works.
Posted by: daedalus2u | October 3, 2010 1:45 PM
Pages
▼
No comments:
Post a Comment
Comments are most welcome! But please:
- No SPAM whatsoever, no supplements, no pharmaceuticals, no herbs or any other advertisements
- Absolutely no quack-doctors pushing their quack-BS websites (and if you are a quack, I will call you out)
- Be critical if you want to, but try to be coherent
Comments are moderated, because I am tired of Gerwyn-V99-The-Idiot and his moronic sockpuppets, and tired of the story of the two dogs, but I will try to publish everything else.
If you are not Gerwyn (and want to tell me something other than the story of the two dogs), then relax and write something! :-)